These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 15652653

  • 1. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 2. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 3. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE.
    Biochemistry; 2004 Apr 06; 43(13):3996-4011. PubMed ID: 15049707
    [Abstract] [Full Text] [Related]

  • 4. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K, Kimura R, Suga S, Ogawa Y, Suda T, Wakui M.
    Peptides; 2006 Jul 06; 27(7):1814-9. PubMed ID: 16513211
    [Abstract] [Full Text] [Related]

  • 5. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J, Fechner K, Beyermann M, Krause E, Wendt N, Bienert M, Rudolph R, Rothemund S.
    Biochemistry; 2005 Feb 08; 44(5):1614-23. PubMed ID: 15683245
    [Abstract] [Full Text] [Related]

  • 6. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
    Jahn O, Tezval H, van Werven L, Eckart K, Spiess J.
    Neuropharmacology; 2004 Aug 08; 47(2):233-42. PubMed ID: 15223302
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
    Dautzenberg FM, Higelin J, Wille S, Brauns O.
    Regul Pept; 2004 Sep 15; 121(1-3):89-97. PubMed ID: 15256278
    [Abstract] [Full Text] [Related]

  • 8. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M, Heinrich N, Fechner K, Furkert J, Zhang W, Kraetke O, Bienert M, Berger H.
    Br J Pharmacol; 2007 Jul 15; 151(6):851-9. PubMed ID: 17533422
    [Abstract] [Full Text] [Related]

  • 9. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF.
    J Pharmacol Exp Ther; 2004 Sep 15; 310(3):1027-34. PubMed ID: 15115804
    [Abstract] [Full Text] [Related]

  • 10. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C, Peinnequin A, Pellissier S, Meregnani J, Sinniger V, Canini F, Bonaz B.
    Peptides; 2006 Jun 15; 27(6):1464-75. PubMed ID: 16337313
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional CRF receptors in BON cells stimulate serotonin release.
    von Mentzer B, Murata Y, Ahlstedt I, Lindström E, Martínez V.
    Biochem Pharmacol; 2007 Mar 15; 73(6):805-13. PubMed ID: 17184738
    [Abstract] [Full Text] [Related]

  • 14. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR, Fleck BA, Gross RS, Crowe PD, Williams JP, Grigoriadis DE.
    Mol Pharmacol; 2008 May 15; 73(5):1371-80. PubMed ID: 18239030
    [Abstract] [Full Text] [Related]

  • 15. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM, Wille S.
    Regul Pept; 2004 May 15; 118(3):165-73. PubMed ID: 15003833
    [Abstract] [Full Text] [Related]

  • 16. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
    Porcher C, Juhem A, Peinnequin A, Sinniger V, Bonaz B.
    Am J Physiol Gastrointest Liver Physiol; 2005 May 15; 288(5):G1091-103. PubMed ID: 15637181
    [Abstract] [Full Text] [Related]

  • 17. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S.
    Peptides; 2004 Oct 15; 25(10):1711-21. PubMed ID: 15476938
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A, Kozicz T, Richter J, Veening JG, Olivier B, Roubos EW.
    J Comp Neurol; 2007 Jun 20; 502(6):973-89. PubMed ID: 17444496
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.